SCHEMBL6168465

SCHEMBL6168465

O=C(c1ccccc1)c1cc2c(Cl)cc(Cl)cc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.67
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
RHEB Q15382 7/20 0.55
ALOX15 P16050 3/20 0.47
CYP1A2 P05177 3/20 0.47
BLM P54132 2/20 0.47
CYP2C9 P11712 2/20 0.47
TSHR P16473 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168641 0.83 FLT3 (0.60) GRIN1MEN1KMT2ANPC1RAB9A
SCHEMBL8499338 0.82 MEN1 (0.71) GRIN1MEN1KMT2ANPC1RAB9A
SCHEMBL29531428 0.80 GRIN1 (1.00) GRIN1MEN1KMT2ARHEBALOX15
SCHEMBL727389 0.80 GRIN1 (1.00) GRIN1MEN1KMT2ARHEBALOX15
SCHEMBL6168680 0.79 MEN1 (0.58) MEN1KMT2ANPC1RAB9ARHEB
SCHEMBL3033007 0.77 GRIN1 (0.74) GRIN1MEN1KMT2ARHEBALOX15
SCHEMBL6170605 0.77 MEN1 (0.78) MEN1KMT2ANPC1RAB9AALOX15
SCHEMBL22529402 0.76 GRIN1 (0.72) GRIN1MEN1KMT2ARHEBALOX15
SCHEMBL20505089 0.76 GRIN1 (0.72) GRIN1MEN1KMT2ARHEBALOX15
SCHEMBL6170489 0.75 MEN1 (0.70) MEN1KMT2ANPC1RAB9AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed